Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD to Present at Wells Fargo 2025 Healthcare Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo...

Key Takeaway: BD (Becton, Dickinson and Company) has announced its presentation at the Wells Fargo 2025 Healthcare Conference scheduled for September 3, 2025. The presentation can be accessed via a live webcast on the company's investor relations website. BD, known for its global presence and commitment to improving health care, emphasizes its role in advancing medical discovery and diagnostics. This conference offers an opportunity for BD to showcase its innovative technologies and solutions that enhance health care delivery.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is a leading global medical technology company.
  • The company is advancing health care through innovative technologies.
  • BD supports clinicians and researchers in enhancing patient care.

Full Press Release Details

FRANKLIN LAKES, N.J. , Aug. 14, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025 at 8:00 a.m. Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD present at the Wells Fargo Healthcare Conference?

BD will present on September 3, 2025, at 8:00 a.m. Eastern Time.

How can I access the live webcast of BD's presentation?

The live webcast can be accessed on BD's investor relations website.

What does BD specialize in?

BD specializes in medical technology, enhancing health and care delivery.

How many employees does BD have?

BD has more than 70,000 employees worldwide.

Where can I find more information about BD?

More information can be found on bd.com and their social media channels.

Last updated: Aug 14, 2025